HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson

HCA Healthcare, Inc. (HCA), Thursday announced a collaboration with Johnson & Johnson (JNJ) to improve health equity, enhance nursing support, and improve patient outcomes.

As per the agreement, Nashville-based HCA Healthcare and Johnson & Johnson will collaborate on a strategic partnership for a scalable program for the early identification of lung cancer in the Black community.

The two companies will work together on healthcare educational programming, training, and other programs that elevate and support nurses with experience and skillsets. HCA Healthcare has more than 93,000 nurses, 182 hospitals, and approximately 2,300 ambulatory sites of care in its system.

HCA Healthcare Research Institute and Johnson & Johnson will collaborate on cardiovascular health initiatives also. A retrospective analysis will be done on patients who suffer from heart arrhythmia, and also on the role of digital health technology in clinical outcomes for patients with Coronary Artery Disease, and Peripheral Artery Disease diseases.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT